rituximab,belimumab
roche,biogen,gsk
[]
bel after rtx targets iga2 anti-dsdna abs and favors formation of anergic/resting b cells while reducing potentially pathogenic b-cell subsets. abs 0978 #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.